2013LeukemiaOpen access

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

Rebecca R. Laborde, Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Ryan A. Knudson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Open full text 92 citations

Abstract

SETBP1 encodes SET-binding protein 1, a binding partner for the multi-function SET protein. This protein is encoded by the SET nuclear oncogene and is involved in apoptosis, transcription and nucleosome assembly. 1 The proposed functional outcome of this interaction is based on in vitro studies that demonstrate a protection of SET protein from protease cleavage that results in inhibition of protein phosphatase 2A activity, leading to higher rates of cell proliferation. 1 Initial identification of germline SETBP1 alterations affecting amino-acid residues between 858 and 871 have been described in patients with Schinzel–Giedion syndrome, associated with a congenital phenotype including mental retardation and facial deformities. 2

Open-access reader

About this research paper

What this paper is about

SETBP1 encodes SET-binding protein 1, a binding partner for the multi-function SET protein. This protein is encoded by the SET nuclear oncogene and is involved in apoptosis, transcription and nucleosome assembly. 1 The proposed functional outcome of this interaction is based on in vitro studies that demonstrate a protection of SET protein from protease cleavage that results in inhibition of protein phosphatase 2A activity, leading to higher rates of cell proliferation. 1 Initial identification of germline SETBP1 alterations affecting amino-acid residues between 858 and 871 have been described in patients with Schinzel–Giedion syndrome, associated with a congenital phenotype including mental retardation and facial deformities. 2

Why it matters

OpenAlex reports 92 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SETBP1 encodes SET-binding protein 1, a binding partner for the multi-function SET protein. This protein is encoded by the SET nuclear oncogene and is involved in apoptosis, transcription and nucleosome assembly. 1 The proposed functional outcome of this interaction is based on in vitro studies that demonstrate a protection of SET protein from protease cleavage that results in inhibition of protein phosphatase 2A activity, leading to higher rates of cell proliferation. 1 Initial identification of germline SETBP1 alterations affecting amino-acid residues between 858 and 871 have been described in patients with Schinzel–Giedion syndrome, associated with a congenital phenotype including mental retardation and facial deformities. 2

Key concepts: Myelofibrosis, Chronic myelomonocytic leukemia, Medicine, Internal medicine, Hematology, Leukemia, Oncology, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML — Research Paper | ScholarLens